pp-002 Injection
Dossier type
CTD
Dossier status
Under development
Country of origin
South Korea
GMP approvals
South Korea
Comments
HBV Vaccine for Chronic Hepatitis B Treatment. Status: Phase 2b – IND submission planned for 2026. Positive 1/2a Clinical Trial results
Manufacturer #38269
Korean clinical-stage biopharmaceutical company developing proprietary adjuvant platform technologies for infectious diseases and cancer